BAP1 and mesothelioma: In particular, the recently introduced immunohistochemical marker BRCA1-associated protein 1 is also particularly useful in determining whether mesothelial cells in cytological specimens are malignant or benign, and germline mutations in BRCA1-associated protein 1 increase susceptibility to mesothelioma.[8]